169 related articles for article (PubMed ID: 29450588)
1. Response rates and recurrence patterns after low-dose radiotherapy with 4 Gy in patients with low-grade lymphomas.
König L; Hörner-Rieber J; Bernhardt D; Hommertgen A; Rieken S; Debus J; Herfarth K
Strahlenther Onkol; 2018 May; 194(5):454-461. PubMed ID: 29450588
[TBL] [Abstract][Full Text] [Related]
2. De-escalated radiotherapy for indolent primary cutaneous B-cell lymphoma.
Oertel M; Elsayad K; Weishaupt C; Steinbrink K; Eich HT
Strahlenther Onkol; 2020 Feb; 196(2):126-131. PubMed ID: 31758232
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy of indolent orbital lymphomas : Two radiation concepts.
König L; Stade R; Rieber J; Debus J; Herfarth K
Strahlenther Onkol; 2016 Jun; 192(6):414-21. PubMed ID: 27160291
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy of extranodal low-grade follicular and marginal zone lymphomas: long-term follow-up of 159 patients.
Elsayad K; Reinartz G; Oertel M; Rehn S; Eismann J; Scobioala S; Berssenbrügge H; Eter N; Weishaupt C; Schmidt HH; Friedrichs B; Grünewald I; Hartmann W; Lenz G; Wardelmann E; Willich N; Eich HT
Strahlenther Onkol; 2020 Feb; 196(2):117-125. PubMed ID: 31732783
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of low-dose radiotherapy (2 Gy × 2) in the treatment of marginal zone and mucosa-associated lymphoid tissue lymphomas.
Cerrato M; Orlandi E; Vella A; Bartoncini S; Iorio GC; Bongiovanni D; Capriotti F; Boccomini C; Vassallo F; Cavallin C; De Luca V; Giglioli FR; Ricardi U; Levis M
Br J Radiol; 2021 Jul; 94(1123):20210012. PubMed ID: 34111959
[TBL] [Abstract][Full Text] [Related]
7. Oncological outcome and recurrence pattern analysis after involved-field irradiation in combination with rituximab for early-stage nodal and extranodal follicular lymphoma.
König L; Herfarth K; Hörner-Rieber J; Dietrich S; Wiegel T; Debus J; Viardot A
Strahlenther Onkol; 2020 Aug; 196(8):705-714. PubMed ID: 32377821
[TBL] [Abstract][Full Text] [Related]
8. Extranodal nonorbital indolent lymphomas of the head and neck: relationship between tumor control and radiotherapy.
MacDermed D; Thurber L; George TI; Hoppe RT; Le QT
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):788-95. PubMed ID: 15183482
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients.
Servitje O; Muniesa C; Benavente Y; Monsálvez V; Garcia-Muret MP; Gallardo F; Domingo-Domenech E; Lucas A; Climent F; Rodriguez-Peralto JL; Ortiz-Romero PL; Sandoval J; Pujol RM; Estrach MT
J Am Acad Dermatol; 2013 Sep; 69(3):357-65. PubMed ID: 23796549
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of radiation therapy of indolent cutaneous B-cell lymphomas and literature review.
Gauci ML; Quero L; Ram-Wolff C; Guillerm S; M'Barek B; Lebbé C; Bagot M; Hennequin C
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1668-1673. PubMed ID: 29578630
[TBL] [Abstract][Full Text] [Related]
11. Renewed interest for low-dose radiation therapy in follicular lymphomas: From biology to clinical applications.
Ciammella P; Luminari S; Arcaini L; Filippi AR
Hematol Oncol; 2018 Dec; 36(5):723-732. PubMed ID: 30146794
[TBL] [Abstract][Full Text] [Related]
12. Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial.
König L; Dreyling M; Dürig J; Engelhard M; Hohloch K; Viardot A; Witzens-Harig M; Kieser M; Klapper W; Pott C; Herfarth K
Trials; 2019 Aug; 20(1):544. PubMed ID: 31470902
[TBL] [Abstract][Full Text] [Related]
13. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University.
Mac Manus MP; Hoppe RT
J Clin Oncol; 1996 Apr; 14(4):1282-90. PubMed ID: 8648385
[TBL] [Abstract][Full Text] [Related]
14. Low-grade non-hodgkin lymphomas.
Tsang RW; Gospodarowicz MK
Semin Radiat Oncol; 2007 Jul; 17(3):198-205. PubMed ID: 17591567
[TBL] [Abstract][Full Text] [Related]
15. Localized low-dose radiotherapy for follicular lymphoma: history, clinical results, mechanisms of action, and future outlooks.
Ganem G; Cartron G; Girinsky T; Haas RL; Cosset JM; Solal-Celigny P
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):975-82. PubMed ID: 20970029
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome and patterns of failure in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy.
Hashimoto N; Sasaki R; Nishimura H; Yoshida K; Miyawaki D; Nakayama M; Uehara K; Okamoto Y; Ejima Y; Azumi A; Matsui T; Sugimura K
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1509-14. PubMed ID: 21664061
[TBL] [Abstract][Full Text] [Related]
17. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome.
Tsang RW; Gospodarowicz MK; Pintilie M; Wells W; Hodgson DC; Sun A; Crump M; Patterson BJ
J Clin Oncol; 2003 Nov; 21(22):4157-64. PubMed ID: 14615444
[TBL] [Abstract][Full Text] [Related]
18. High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas.
Haas RL; Poortmans P; de Jong D; Aleman BM; Dewit LG; Verheij M; Hart AA; van Oers MH; van der Hulst M; Baars JW; Bartelink H
J Clin Oncol; 2003 Jul; 21(13):2474-80. PubMed ID: 12829665
[TBL] [Abstract][Full Text] [Related]
19. Ultra-low-dose radiotherapy in the treatment of ocular adnexal lymphoma: a prospective study.
Yang X; Wang R; Yuan X; Yao S; Wang C; Cheng J
Radiat Oncol; 2022 Dec; 17(1):208. PubMed ID: 36539787
[TBL] [Abstract][Full Text] [Related]
20. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]